Pancuronium bromide,

Code: p1918-100mg D2-231

Application

Pancuronium Bromide has been used as an analgesic in various experiments.

Biochem/physiol Actions

Aminosteroidal neuromuscular blocki...


read more

Your Price
£391.00 100MG
£469.20 inc. VAT

Application

Pancuronium Bromide has been used as an analgesic in various experiments.

Biochem/physiol Actions

Aminosteroidal neuromuscular blocking agent; skeletal muscle relaxant

Features and Benefits

This compound was developed by Organon. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

General description

Pancuronium bromide is a biquarternary amino steroid. It blocks muscarinic acetylcholine receptors (M2) in the heart. Pancuronium has vagolytic and sympathomimetic properties. It is associated with tachycardia and hypertension.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

formpowder
Gene Informationhuman ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146)
InChI keyNPIJXCQZLFKBMV-YTGGZNJNSA-L
InChI1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1
originatorOrganon
Quality Level100
SMILES string[Br-].[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]5(C)CCCCC5)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]6(C)CCCCC6
Code
Description
Unit Size
List Price
Qty
P1918-10MG
Unit:10MG
List Price: £61.90
Source:List Price
ADD
P1918-250MG
Unit:250MG
List Price: £780.00
Source:List Price
ADD
P1918-50MG
Unit:50MG
List Price: £220.00
Source:List Price
ADD
Cas Number15500-66-0
Hazard Class6.1
Un Number2811
Pack Group3
This product has met the following criteria to qualify for the following awards: